Cargando…

Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer

Laminin Subunit Beta 3 (LAMB3) is a transcription factor and participates in the coding of laminin. It plays an important role in cell proliferation, adhesion, and transfer by regulating various target genes and signaling pathways. However, the role of LAMB3 in human pan-cancer immunology and progno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanghao, Li, Guoyu, Wang, ZhiYuan, Wang, Weizhou, Wang, Xiaofang, Luo, Xuan, Zhao, Juan, Li, Fangfang, Bian, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415034/ https://www.ncbi.nlm.nih.gov/pubmed/37577750 http://dx.doi.org/10.3389/fmolb.2023.1157970

Ejemplares similares

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort
por: Jia, Chenguang, et al.
Publicado: (2022)

Multi-Omics Analysis of the Effects of Smoking on Human Tumors
por: Wang, Rui, et al.
Publicado: (2021)

Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
por: Feng, Huan, et al.
Publicado: (2020)

Comprehensive Analysis of the Prognostic and Immunological Role of PAFAH1B in Pan-Cancer
por: Yuan, Yixiao, et al.
Publicado: (2022)

KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
por: Qiu, Meng-jun, et al.
Publicado: (2021)

The Predictive Competing Endogenous RNA Regulatory Networks and Potential Prognostic and Immunological Roles of Cyclin A2 in Pan-Cancer Analysis
por: Chen, Shenyong, et al.
Publicado: (2022)

A pan-cancer analysis reveals CHD1L as a prognostic and immunological biomarker in several human cancers
por: Soltan, Mohamed A., et al.
Publicado: (2023)

Comprehensive pan-cancer investigation: unraveling the oncogenic, prognostic, and immunological significance of Abelson interactor family member 3 gene in human malignancies
por: Sun, Aijun, et al.
Publicado: (2023)

Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer
por: Zhao, Lianfang, et al.
Publicado: (2023)

PTBPs: An immunomodulatory-related prognostic biomarker in pan-cancer
por: Chen, Chen, et al.
Publicado: (2022)

Systematic analysis of MCM3 in pediatric medulloblastoma via multi-omics analysis
por: Cao, Liangliang, et al.
Publicado: (2022)

Editorial: Leveraging machine learning for omics-driven biomarker discovery
por: Li, Sheng, et al.
Publicado: (2023)

Integrative Analysis of MALT1 as a Potential Therapeutic Target for Prostate Cancer and its Immunological Role in Pan-Cancer
por: Tan, Haotian, et al.
Publicado: (2021)

Comprehensive Analysis Reveals USP45 as a Novel Putative Oncogene in Pan-Cancer
por: Li, Kai, et al.
Publicado: (2022)

Identification of immune-related ferroptosis prognostic marker and in-depth bioinformatics exploration of multi-omics mechanisms in thyroid cancer
por: Fan, Xin, et al.
Publicado: (2022)

Corrigendum: Systematic analysis of MCM3 in pediatric medulloblastoma via multi-omics analysis
por: Cao, Liangliang, et al.
Publicado: (2022)

Editorial: Recent Advances in In Vitro and In Vivo Multi-Omics Analyses of Extracellular Vesicles: Therapeutic Targets and Biomarkers
por: Manfredi, Marcello, et al.
Publicado: (2021)

Machine learning combining multi-omics data and network algorithms identifies adrenocortical carcinoma prognostic biomarkers
por: Martin-Hernandez, Roberto, et al.
Publicado: (2023)

Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
por: Liu, Yi, et al.
Publicado: (2021)

CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis
por: Guo, Lihao, et al.
Publicado: (2021)

Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
por: Tu, Zewei, et al.
Publicado: (2021)

Identifying tumor immunity-associated molecular features in liver hepatocellular carcinoma by multi-omics analysis
por: Shen, Qianyun, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals the Multidimensional Expression and Prognostic and Immunologic Roles of VSTM2L in Cancer
por: Zhang, Shuyi, et al.
Publicado: (2022)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

Editorial: Multi-omics: Trends and applications in clinical research
por: Sussulini, Alessandra, et al.
Publicado: (2022)

Investigation on acquired palbociclib resistance by LC-MS based multi-omics analysis
por: Xue, Zhichao, et al.
Publicado: (2023)

Identification of Four Novel Prognostic Biomarkers and Construction of Two Nomograms in Adrenocortical Carcinoma: A Multi-Omics Data Study via Bioinformatics and Machine Learning Methods
por: Yi, Xiaochun, et al.
Publicado: (2022)

Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles
por: Lu, Xiaona, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of Heat Shock Protein 110, 90, 70, and 60 Families
por: Yan, Li-rong, et al.
Publicado: (2021)

Computational approaches for network-based integrative multi-omics analysis
por: Agamah, Francis E., et al.
Publicado: (2022)

Editorial: Advances in methods and tools for multi-omics data analysis
por: Cominetti, Ornella, et al.
Publicado: (2023)

Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma
por: Chen, Xiaochuan, et al.
Publicado: (2021)

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer
por: Xie, Xiaodong, et al.
Publicado: (2023)

An Integrative Pan-Cancer Analysis of PBK in Human Tumors
por: Wen, Huantao, et al.
Publicado: (2021)

Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer
por: Lv, Zhengtong, et al.
Publicado: (2021)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

Editorial: AI and Multi-Omics for Rare Diseases: Challenges, Advances and Perspectives
por: Bottini, Silvia, et al.
Publicado: (2021)

Using the multi-omics approach to reveal the silk composition in Plectrocnemia conspersa
por: Rouhová, Lenka, et al.
Publicado: (2022)

Multi-omics analysis reveals the prognostic and tumor micro-environmental value of lumican in multiple cancer types
por: Guo, Zehuai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gieiv72qja5ru831gaq6qeknat